5-fluorodopamine has been researched along with MEA 2a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilias, I; Pacak, K | 1 |
| Gourgiotis, L; Merino, MJ; Pacak, K; Reynolds, JC; Sarlis, NJ; VanWaes, C | 1 |
1 review(s) available for 5-fluorodopamine and MEA 2a
| Article | Year |
|---|---|
Diagnosis, localization and treatment of pheochromocytoma in MEN 2 syndrome.
Topics: Adrenal Gland Neoplasms; Dopamine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 2a; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
1 other study(ies) available for 5-fluorodopamine and MEA 2a
| Article | Year |
|---|---|
Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography.
Topics: Adult; Carcinoma, Medullary; Dopamine; Female; Fluorine Radioisotopes; Humans; Multiple Endocrine Neoplasia Type 2a; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |